5 Electrolyte Safety
Learn how to safely prepare, administer, monitor, and respond to concerns involving concentrated electrolyte infusions and hypertonic saline.
High-alert electrolyte safety
Concentrated electrolytes and are because errors in dose, dilution, route, or infusion rate can cause severe harm. concentrate, , potassium phosphates, and hypertonic sodium chloride are identified as .
Use the current order, product label, approved compatibility reference, and facility policy. If any part of an order or setup is unclear, pause and clarify with the prescriber or pharmacist before administration.
Administering safely
concentrate must be diluted and given by controlled intravenous infusion. Never administer it undiluted or by intravenous push. If an order requests an intravenous push, do not administer it; hold the medication and promptly clarify the order with the prescriber and pharmacist.
Before proceeding, confirm the intended dose, dilution, route, and rate. Safe administration depends on all of these factors, as well as the access and appropriate monitoring; correct pump arithmetic alone does not make an unsafe concentration or route acceptable.
Check concentration, access, and rate
For an order of in over , the pump rate is:
The solution concentration is:
Before starting, verify that the prescribed concentration and the proposed peripheral route meet facility policy and product-specific instructions. If they do not, or if the policy is unclear, pause and clarify rather than relying on the rate calculation alone. Potassium infusions require controlled delivery and appropriate monitoring; product labeling describes usual limits and more intensive monitoring for urgent, faster replacement.
and blood products
Do not administer sodium chloride through the same administration set as whole blood or cellular blood components. Arrange separate administration according to facility policy.
can cause fluid or solute overload. Monitor fluid status and ordered electrolyte results; rapid changes in serum sodium can be dangerous.
Preparing and monitoring
Before administering an intravenous infusion prepared from a vial, verify that the dose is prepared at the ordered, approved dilution. Product labeling states that intravenous infusion solutions must be diluted to a concentration of or less; do not assume that a concentrated vial is ready to infuse.
Check renal function and ordered magnesium monitoring, and assess for signs of toxicity under the relevant protocol. Dosing must be individualized, and impaired renal excretion increases the risk of accumulation. For obstetric use, follow the specific protocol, including its respiratory and reflex monitoring requirements.
Verify intravenous compatibility
If compatibility cannot be confirmed for a second medication ordered through the same Y-site as an electrolyte infusion, do not connect the medications until compatibility has been checked in an approved, current injectable-drug reference or confirmed by a pharmacist. If compatibility cannot be established, use a separate line or another approved administration plan.
Compatibility can depend on the drugs, concentrations, diluents, and conditions of administration. Do not infer compatibility from appearance alone.
Responding to infusion concerns
If a patient reports burning at an intravenous site during a potassium infusion and a new rhythm change appears on the monitor, stop or pause the infusion. Promptly assess the patient and site, then escalate according to the patient's condition and facility protocol. Notify the responsible clinician and pharmacist; activate emergency response if the patient is unstable.
Local pain may signal an infusion-site complication, while a new rhythm change may indicate a serious clinical problem. Do not restart the infusion until the cause and a safe plan are clarified.
More generally, monitor the patient, infusion site, and ordered laboratory results, with additional monitoring specified by the medication and protocol. Stop and escalate when an order, compatibility, patient response, or infusion setup raises a safety concern.